These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

454 related items for PubMed ID: 10786828

  • 1. Skeletal resistance to 1,25-dihydroxyvitamin D3 in osteopetrotic rats.
    Safadi FF, Hermey DC, Popoff SN, Seifert MF.
    Endocrine; 1999 Dec; 11(3):309-19. PubMed ID: 10786828
    [Abstract] [Full Text] [Related]

  • 2. Interdependence of skeletal sclerosis and elevated circulating levels of 1,25-dihydroxyvitamin D in osteopetrotic (op and tl) rats.
    Popoff SN, Osier LK, Zerwekh JE, Marks SC.
    Bone; 1994 Dec; 15(5):515-22. PubMed ID: 7980962
    [Abstract] [Full Text] [Related]

  • 3. Effects of 1,25-dihydroxyvitamin D3 on bone resorption and natural immunity in osteopetrotic (ia) rats.
    Schneider GB, Relfson M, Langman CB.
    J Bone Miner Res; 1994 Apr; 9(4):585-91. PubMed ID: 8030447
    [Abstract] [Full Text] [Related]

  • 4. Osteoblasts from the toothless (osteopetrotic) mutation in the rat are unable to direct bone resorption by normal osteoclasts in response to 1,25-dihydroxyvitamin D.
    Sundquist KT, Jackson ME, Hermey DC, Marks SC.
    Tissue Cell; 1995 Oct; 27(5):569-74. PubMed ID: 7491626
    [Abstract] [Full Text] [Related]

  • 5. Effects of 1,25 dihydroxyvitamin D on osteoclast number and cytochemistry in normal and osteopetrotic (os) rabbits.
    Grise MA, Marks SC, MacKay CA, Popoff SN.
    Am J Anat; 1990 Nov; 189(3):261-6. PubMed ID: 2148052
    [Abstract] [Full Text] [Related]

  • 6. Regulation of mineral homeostasis in osteopetrotic (op) rats.
    Hermey DC, Ireland RA, Zerwekh JE, Popoff SN.
    Am J Physiol; 1995 Feb; 268(2 Pt 1):E312-7. PubMed ID: 7864108
    [Abstract] [Full Text] [Related]

  • 7. Treatment of congenital osteopetrosis in the rabbit with high-dose 1,25-dihydroxyvitamin D.
    Popoff SN, McGuire JL, Zerwekh JE, Marks SC.
    J Bone Miner Res; 1989 Feb; 4(1):57-67. PubMed ID: 2718779
    [Abstract] [Full Text] [Related]

  • 8. Osteopetrosis in the rat: coexistence of reductions in osteocalcin and bone resorption.
    Lian JB, Marks SC.
    Endocrinology; 1990 Feb; 126(2):955-62. PubMed ID: 2298176
    [Abstract] [Full Text] [Related]

  • 9. Expression of the vitamin D receptor in the intestine and kidney of osteopetrotic rats.
    Hermey DC, Popoff SN.
    Endocrinology; 1995 Oct; 136(10):4558-64. PubMed ID: 7664677
    [Abstract] [Full Text] [Related]

  • 10. Hyperresponsiveness of vitamin D receptor gene expression to 1,25-dihydroxyvitamin D3. A new characteristic of genetic hypercalciuric stone-forming rats.
    Yao J, Kathpalia P, Bushinsky DA, Favus MJ.
    J Clin Invest; 1998 May 15; 101(10):2223-32. PubMed ID: 9593778
    [Abstract] [Full Text] [Related]

  • 11. Reduced bone resorption in toothless (osteopetrotic) rats--an abnormality of osteoblasts related to their inability to activate osteoclast activity in vitro.
    Hermey DC, Popoff SN, Marks SC.
    Connect Tissue Res; 1996 May 15; 35(1-4):273-8. PubMed ID: 9084666
    [Abstract] [Full Text] [Related]

  • 12. Bone turnover in rats treated with 1,25-dihydroxyvitamin D3, 25-hydroxyvitamin D3 or 24,25-dihydroxyvitamin D3.
    Mortensen BM, Gautvik KM, Gordeladze JO.
    Biosci Rep; 1993 Feb 15; 13(1):27-39. PubMed ID: 8392394
    [Abstract] [Full Text] [Related]

  • 13. Deficiency of osteoclasts in osteopetrotic mice is due to a defect in the local microenvironment provided by osteoblastic cells.
    Takahashi N, Udagawa N, Akatsu T, Tanaka H, Isogai Y, Suda T.
    Endocrinology; 1991 Apr 15; 128(4):1792-6. PubMed ID: 2004603
    [Abstract] [Full Text] [Related]

  • 14. Effect of dietary calcium on the response of bone to 1,25 (OH)2D3.
    Boyce RW, Weisbrode SE.
    Lab Invest; 1983 Jun 15; 48(6):683-9. PubMed ID: 6687909
    [Abstract] [Full Text] [Related]

  • 15. Abnormalities of phosphoprotein gene expression in three osteopetrotic rat mutations: elevated mRNA transcripts, protein synthesis, and accumulation in bone of mutant animals.
    Shalhoub V, Bettencourt B, Jackson ME, MacKay CA, Glimcher MJ, Marks SC, Stein GS, Lian JB.
    J Cell Physiol; 1994 Jan 15; 158(1):110-20. PubMed ID: 8263018
    [Abstract] [Full Text] [Related]

  • 16. 1,25-dihydroxyvitamin D3 as well as its analogue OCT lower blood calcium through inhibition of bone resorption in hypercalcemic rats with continuous parathyroid hormone-related peptide infusion.
    Endo K, Katsumata K, Hirata M, Masaki T, Kubodera N, Nakamura T, Ikeda K, Ogata E.
    J Bone Miner Res; 2000 Jan 15; 15(1):175-81. PubMed ID: 10646127
    [Abstract] [Full Text] [Related]

  • 17. The roles of calcium and 1,25-dihydroxyvitamin D3 in the regulation of vitamin D receptor expression by rat parathyroid glands.
    Brown AJ, Zhong M, Finch J, Ritter C, Slatopolsky E.
    Endocrinology; 1995 Apr 15; 136(4):1419-25. PubMed ID: 7895652
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Cultured circulating mononuclear cells from osteopetrotic infants express the osteoclast-associated vitronectin receptor and form multinucleated cells in response to 1,25-dihydroxyvitamin D3.
    Cournot G, Petrovic M, Trubert CL, Cormier C, Girault D, Fischer A, Garabedian M.
    J Bone Miner Res; 1993 Jan 15; 8(1):61-70. PubMed ID: 7678950
    [Abstract] [Full Text] [Related]

  • 20. Chronic administration of 1,25-dihydroxyvitamin D3: increased bone but impaired mineralization.
    Wronski TJ, Halloran BP, Bikle DD, Globus RK, Morey-Holton ER.
    Endocrinology; 1986 Dec 15; 119(6):2580-5. PubMed ID: 3780540
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.